SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15 (d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 2, 2004

 

THE ARISTOTLE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE                                                                             0-14669                                                  06-116854

(State or other                                                         (Commission File Number)                                (IRS Employer

jurisdiction of incorporation)                                                                                                              Identification No.)

 

96 Cummings Point Road, Stamford, CT                          06902

                                                                 (Address of principal executive offices)                  (Zip Code)

 

 

Registrant's telephone number, including area code: (203) 358-8000

 

 

(Former name or former address, if changed since last report)

 

 

 

Page 1 of 2 Pages

 

Page 2 of 2 Pages

Item 7. Exhibits.

Exhibit 99.1 - Press release of The Aristotle Corporation, dated August 2, 2004.

 

Item 12. Disclosure of Results of Operations and Financial Condition.

On August 2, 2004, The Aristotle Corporation issued a press release announcing financial results for the quarter ended June 30, 2004, a copy of which is attached as Exhibit 99.1.

The information in this Form 8-K and the Exhibit attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE ARISTOTLE CORPORATION

(Registrant)

 

By: /s/ H. William Smith

Name: H. William Smith

Title: Vice President, General Counsel

and Secretary

Date: August 2, 2004

EXHIBITS

Exhibit 99.1 Press release issued August 2, 2004.

For Immediate Release News Release

Contacts:

Bill Smith or Dean Johnson

The Aristotle Corporation

Phone: (203) 358-8000 or (920) 563-2446

Fax: (203) 358-0179 or (920) 563-0234

wsmith@ihc-geneve.com

int@enasco.com

The Aristotle Corporation Announces

2004 Second Quarter Results

Stamford, CT, August 2, 2004 - The Aristotle Corporation (NASDAQ: ARTL; ARTLP) announced today its results of operations for the second quarter of 2004.

For the three months ended June 30, 2004, net sales increased 3.8% to $44.6 million from $43.0 million in the second quarter of 2003. Earnings before income taxes increased 11.1% to $6.1 million from $5.5 million in the 2003 second quarter, and net earnings increased to $3.7 million compared to $3.3 million. Net income applicable to common stockholders in the second quarter of 2004 was $1.6 million, or $.09 per diluted common share, which includes the accretion of $2.1 million of preferred dividends on the Series I and Series J preferred stocks issued on June 17, 2002. In the 2003 second quarter, net income applicable to common stockholders was $1.2 million, or $.07 per diluted common share. The prior year results also include the accretion of $2.1 million in preferred dividends.

For the six months ended June 30, 2004, net sales increased 6.7% to $83.6 million from $78.4 million in the first six months of 2003. Earnings before income taxes for year-to-date 2004 increased 27.4% to $11.1 million from $8.7 million in 2003, and net earnings increased to $6.8 million from $5.3 million. Including the accretion of $4.3 million of preferred dividends in each of the six-month periods of 2004 and 2003, net income applicable to common stockholders for year-to-date 2004 was $2.5 million, or $.14 per diluted common share, compared to $1.0 million, or $.06 per diluted common share for year-to-date 2003.

Although the reported net earnings for the second quarters of 2004 and 2003 are shown after-tax, approximately $1.8 million and $1.4 million, respectively, of cash from operations was retained in Aristotle as a result of the utilization of Federal net operating tax loss carryforwards ("NOL's"). In the six month periods of 2004 and 2003, approximately $3.3 million and $2.4 million, respectively, of cash from operations was retained as a result of this utilization of NOL's. Except for Federal alternative minimum tax obligations arising from limitations on the NOL's in 2004 and future years, Aristotle anticipates that the utilization of available NOL's to offset future Federal taxable income will result in Aristotle not using its cash resources to pay Federal income taxes for approximately the next three years. At June 30, 2004, the Condensed Consolidated Balance Sheet contains a net deferred tax asset of $20.0 million, net of a valuation allowance of $11.0 million. Substantially all of this net deferred tax asset relates to the NOL's. The valuation allowance has been established to reflect the estimate of NOL's that are expected to expire unutilized.

Steven B. Lapin, Aristotle's President and Chief Operating Officer, stated, "We are pleased to report to our stockholders that earnings per diluted common share grew to $.09 in the second quarter from $.07 per diluted common share in the second quarter of 2003, and that through six months, Aristotle has increased its earnings per diluted common share to $.14, more than double the $.06 per share earned in the first six months of 2003. Please keep in mind that these positive results come at a time when most states continue to be severely challenged in their budget demands, which is a situation that could cause further pressures on certain areas of your Company's educational segment throughout the balance of the year. "

Mr. Lapin added, "While the earnings per share growth was aided by revenue growth of 3.8% and 6.7% for the second quarter and year-to-date periods, respectively, your Company continues to improve EBITDA at rates greater than its sales growth. For the current quarter and year-to-date periods, EBITDA increased by 8.2% and 23.4%, respectively. This performance improvement is driven by the expansion of proprietary product sales, particularly in the health care training product lines in domestic and international markets. In addition, cost control programs initiated in the past twelve months continue to provide efficiency gains in reported results."

Dean T. Johnson, Aristotle's Chief Financial Officer, noted, "A key strength of Aristotle's business is its ability to generate cash consistently. In the quarter ended June 30, 2004, Aristotle generated $5.9 million of cash from operations, compared to $5.1 million in the same period of 2003. Aristotle used the cash flow to reduce its revolving debt by $2.6 million in this year's second quarter. In addition to providing its working capital needs for the peak shipping season in the upcoming third quarter, future cash flow will be available as a capital resource for acquisition opportunities."

Mr. Johnson also noted, "The attached balance sheet presents the strong financial condition of your Company. At June 30, 2004, the reported tangible net worth, i.e. stockholders' equity less goodwill, was $51.1 million, increasing 11.2% from $46.0 million at the same time last year. And, in the past twelve months, Aristotle's total debt to equity ratio, i.e. total liabilities compared to total stockholders' equity, has improved to .8 to 1, compared to 1.2 to 1 at June 30, 2003."

In providing EBITDA information, Aristotle offers a non-GAAP financial measure to complement its condensed consolidated financial statements presented in accordance with GAAP. This non-GAAP financial measure is intended to supplement the reader's overall understanding of Aristotle's current financial performance. However, this non-GAAP financial measure is not intended to supercede or replace Aristotle's GAAP results. A reconciliation of the non-GAAP results to the GAAP results is provided in the "Reconciliation of GAAP Net Earnings to EBITDA" schedule below. EBITDA is defined as earnings before interest and other income, income taxes, depreciation and amortization.

 

About Aristotle

The Aristotle Corporation, founded in 1986, and headquartered in Stamford, CT, is a leading manufacturer and global distributor of educational, health, medical technology and agricultural products. A selection of over 80,000 items is offered, primarily through catalogs carrying the brand of Nasco (founded in 1941), as well as those bearing the brands of Simulaids, Triarco, Summit Learning, Hubbard Scientific, Scott Resources, Spectrum Educational Supplies, Haan Crafts and To-Sew. Products include educational materials and supplies for substantially all K-12 curricula, molded plastics, biological materials, medical simulators and items for the agricultural, senior care and food industries. Aristotle has approximately 800 employees at its operations in Fort Atkinson, WI, Modesto, CA, Fort Collins, CO, Plymouth, MN, Woodstock, NY, Chippewa Falls, WI, Otterbein, IN and Newmarket, Ontario, Canada.

There are approximately 17.1 million shares outstanding of Aristotle common stock (NASDAQ: ARTL) and approximately 1.1 million shares outstanding of 11%, cumulative, convertible, voting, Series I preferred stock (NASDAQ: ARTLP); there are also approximately 11.0 million privately-held shares outstanding of 12%, cumulative, non-convertible, non-voting shares of Series J preferred stock. Aristotle has about 4,000 shareholders of record.

Further information about Aristotle can be obtained on its website, at www.aristotlecorp.net.

Safe Harbor under the Private Securities Litigation Reform Act of 1995

To the extent that any of the statements contained in this release are forward-looking, such statements are based on current expectations that involve a number of uncertainties and risks. Aristotle cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: (i) the ability of Aristotle to obtain financing and additional capital to fund its business strategy on acceptable terms, if at all; (ii) the ability of Aristotle on a timely basis to find, prudently negotiate and consummate additional acquisitions; (iii) the ability of Aristotle to manage any to-be acquired businesses; (iv) the ability of Aristotle to retain and utilize its Federal net operating tax loss carryforward position; and (v) general economic conditions. As a result, Aristotle's future development efforts involve a high degree of risk. For further information, please see Aristotle's filings with the Securities and Exchange Commission, including its Forms 10-K, 10-Q and 8-K.

THE ARISTOTLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per share data)

(Unaudited)

 

Three Months Ended

Six Months Ended

June 30,

June 30,

2004

2003

2004

2003

Net sales

$

44,612

42,961

83,632

78,402

Cost of sales

27,781

26,734

51,612

48,937

Gross profit

16,831

16,227

32,020

29,465

Selling and administrative expense

10,409

10,332

20,285

20,118

Earnings from operations

6,422

5,895

11,735

9,347

Other expense (income):

Interest expense

289

371

602

679

Other, net

(9)

(6)

21

(55)

280

365

623

624

Earnings before income taxes

6,142

5,530

11,112

8,723

Income taxes:

Current

578

770

1,034

979

Deferred

1,806

1,414

3,275

2,446

2,384

2,184

4,309

3,425

Net earnings

3,758

3,346

6,803

5,298

Preferred dividends

2,158

2,150

4,321

4,300

Net earnings applicable to common stockholders

$

1,600

1,196

2,482

998

Earnings per common share:

Basic

$

.09

.07

0.15

.06

Diluted

$

.09

.07

0.14

.06

Weighted average common shares outstanding:

Basic

17,111,607

17,031,687

17,105,304

17,031,687

Diluted

17,289,123

17,120,547

17,284,349

17,144,852

RECONCILIATION OF GAAP NET EARNINGS TO EBITDA

(in thousands)

(unaudited)

Three Months Ended

Six Months Ended

June 30,

June 30,

2004

2003

2004

2003

                 
 

Net earnings

$

3,758

 

3,346

 

6,803

 

5,298

 

Add:

               
   

Income taxes

 

2,384

 

2,184

 

4,309

 

3,425

   

Interest expense and other income

 

280

 

365

 

623

 

624

   

Depreciation and amortization

 

444

 

448

 

860

 

858

EBITDA

$

6,866

6,343

12,595

10,205

 

THE ARISTOTLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

Assets

June 30,

2004

December 31, 2003

June 30, 2003

(unaudited)

(unaudited)

Current assets:

Cash and cash equivalents

$

4,477

5,566

8,850

Accounts receivable, net

17,651

11,881

19,152

Inventories

36,241

29,157

34,705

Prepaid expenses and other

3,889

5,598

6,102

Refundable income taxes

-

344

-

Deferred income taxes

8,184

8,184

7,251

Total current assets

70,442

60,730

76,060

Property, plant and equipment, net

17,065

17,340

17,126

Goodwill

11,393

11,509

10,908

Deferred income taxes

11,806

15,081

19,315

Other assets

409

454

333

Total assets

$

111,115

105,114

123,742

Liabilities and Stockholders' Equity

Current liabilities:

Current installments of long-term debt

$

3,548

1,415

10,560

Trade accounts payable

11,048

5,874

12,216

Accrued expenses

5,067

4,537

3,798

Accrued dividends payable

2,158

2,154

2,150

Income taxes

16

-

690

Total current liabilities

21,837

13,980

29,414

Long-term debt, less current installments

26,799

31,290

37,463

Stockholders' equity:

Preferred stock, Series I

6,580

6,412

6,280

Preferred stock, Series J

65,760

65,760

65,760

Common stock

171

171

170

Additional paid-in capital

1,184

860

512

Accumulated deficit

(10,775)

(13,257)

(15,626)

Accumulated other comprehensive loss

(441)

(102)

(231)

Total stockholders' equity

62,479

59,844

56,865

Total liabilities and stockholders' equity

$

111,115

105,114

123,742